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Available online 19 January 2009Background: The aim of the present study is to compare suicide ideation among women in the
pre-, peri-, and post-menopause using a cross-sectional household survey of non-institutionalised
adults from six European countries.
Methods: In total, 8794 out of 21,425 respondents provided data for the following study. To use
men as a comparison group, we defined three different groups of male subjects, based on the
mean age of the women groups.
Results: We found an increased risk of suicide ideation among women in their peri-menopause
compared with women in their pre- or post-menopause and men. This finding was
independent of mood and anxiety disorders.
Limitations: Some categories showed few individuals. The cross-sectional design of our study
does not allow us to conclude causal relationship between variables.
Conclusion: The occurrence of suicide ideation varies across the reproductive life cycle of women.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Perimenopause1. Introduction
The study of the relationship betweenmood disorders and
reproductive life cycle of women is relevant. Despite
controversies, it seems that women reproductive phases
(i.e. pre, peri and post-menopause) have an effect on the
frequency, presentation, and course of mood disorders
(Cohen, 2003), and that the perimenopause phase is one of
special risk for developing depression (Prior, 1998; Soares,
2008). Besides, there are associations between premenstrualació Sant Joan de Déu,
ental (CIBERSAM)C/
+34 936406350x2356.
All rights reserved.disphoric disorder and lifetime experience of depression
(APA, 1994). Thus, these findings suggest that gonadal
hormone level fluctuations across reproductive cycle could
partially explain such effects (Freeman et al., 2004).
Suicide is probably the most negative outcome of depres-
sion. Some data seems to point out that there could be a
relationship between menstrual cycle and suicidal ideation,
being it more common in those phases of the menstrual cycle
when oestrogen levels are low (Saunders and Hawton, 2006).
However, to date, we have not found the data regarding the
relationship between women reproductive life cycle and
suicidal ideation.
The aim of the present study is to compare suicide ideation
among women in the pre-, peri-, and post-menopause in a
large epidemiological European sample.
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2.1. Sample
Cross-sectional household survey of non-institutionalised
adults (18 years or older) from Belgium, France, Germany,
Italy, the Netherlands, and Spain. In total, 21,425 respondents
provided data between January 2001 and August 2003.
For optimising the length of the interview, two main
questionnaire itineraries were defined.Women of the presentTable 1
Sociodemographic and clinical characteristics of the sample and presence of suicide
Women
Pre-menopause Peri-menopause Post-
% (n) 57.3% 2.0% 40.7
(2787) (118) (201
Mean age (SD) 35.62 50.42 63.6
(9.22) (6.60) (10.4
12-month mental disorders % (n)
No 12-month mental disorders 84.78% 81.39% 41.54
(2112) (88) (156
Only 12-month mood disorders 3.27% 4.16% 3.36
(230) (10) (164
Only 12-month anxiety disorders 9.05% 10.12% 7.24%
(286) (12) (185
12-month comorbid mood and
anxiety disorders
2.9% 4.34% 2.02
(159) (8) (103
Marital status % (n)
Married 66.1% 80.7% 65.2
(1851) (88) (123
Previously married 5.4% 13.2% 28.6
(254) (24) (657
Never married 28.4% 6.1% 6.2%
(688) (6) (125
Number of children % (n)
Without children 39.1% 12.5% 12.1%
(979) (13) (236
One child 19.1% 16.0% 18.3%
(575) (21) (336
2 o more children 41.8% 71.6% 69.6
(1233) (84) (143
Employment status % (n)
Working 70.3% 55.8% 20.7
(1931) (65) (470
Homemaker 15.7% 21.7% 20.0
(459) (31) (458
Not working
(student, retired, sick leave)
14.0% 22.5% 59.3
(403) (22) (108
Country % (n)
Belgium 3.8% 2.22% 3.9%
(319) (11) (224
France 21.74% 26.71% 18.75
(487) (21) (315
Germany 29.48% 35.28% 32.6
(405) (26) (293
Italy 22.38% 10.94% 23.7
(552) (15) (362
The Netherlands 6.56% 5.13% 5.99
(370) (13) (256
Spain 16.04% 19.71% 14.92
(654) (32) (563
Presence of suicide ideation % (n) 1.1% 7.8% 1.0%
(64) (7) (27)study answered the long interview (containing questions
about menstrual periods). The long interview included all
respondents who endorsed the screening questions for
mental disorders (high risk for mental disorders group)
plus a random 25% of low risk individuals. Men followed
the same path. After listwise deletion, there was a total of
4918 women and 3689 men with complete data for the
present study. A detailed description of sampling and
methods has been previously published (Alonso et al.,
2004).ideation.
Men
menopause 18–45 years old 46–57 years old 58 years and older
% 53.2% 19.5% 27.2%
3) (1833) (796) (1060)
7 32.99 51.38 68.68
8) (7.56) (3.37) (4.79)
% 92.00% 92.42% 95.54%
1) (1554) (685) (959)
% 2.48% 1.74% 1.9%
) (109) (38) (56)
4.56% 4.17% 2.35%
) (120) (49) (35)
% 0.96% 1.67% 0.21%
) (50) (24) (10)
% 53.4% 83.6% 84.4%
1) (1038) (613) (853)
% 3.3% 8.0% 10.8%
) (84) (105) (150)
43.3% 8.4% 4.8%
) (711) (78) (57)
57.1% 13.3% 13.6%
) (961) (127) (149)
14.6% 18.4% 18.5%
) (301) (146) (169)
% 28.4% 68.3% 67.8%
9) (568) (523) (738)
% 81.2% 87.5% 17.4%
) (1546) (651) (157)
% 003% 0.1% 0.1%
) (5) (2) (2)
% 18.6% 12.4% 82.4%
5) (282) (143) (901)
3.89% 3.36% 3.93%
) (234) (104) (128)
% 20.73% 21.77% 18.61%
) (326) (140) (118)
6% 31.07% 27.73% 35.25%
) (274) (110) (177)
8% 21.31% 25.61% 21.95%
) (399) (190) (220)
% 6.49% 6.7% 5.36%
) (209) (117) (124)
% 16.5% 14.83% 14.91%
) (391) (135) (293)
0.8% 1.0% 0.6%
(34) (19) (6)
Table 2
Prevalence of suicide ideation across reproductive cycle in women by mental
disorder category.
Pre-menopause Peri-menopause Post-menopause
No mental disorder 0.52% 8.22% 0.56%
(11) (4) (8)
Only 12-month
mood disorders
5.88% 14.16% 4.08%
(17) (2) (7)
Only 12-month
anxiety disorders
1.43% 0 0.88%
(7) (4)
12-month comorbid
mood and anxiety
disorders
13.01% 12.57% 13.57%
(29) (1) (8)
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2.2. Measures
Women who reported they still had menstrual periods or
whose periods stopped temporarily because of birth control,
pregnancy, diet, or extreme exercise, were considered as
being in their pre-menopause. Women who stopped having
periods temporarily because of possible start of menopause or
whose periods stopped permanently but had passed less than
one year since the last menstrual period, were considered as
being in their peri-menopause. Finally, women who stopped
having menstrual periods permanently for more than one
year were coded as being in the post-menopause.
In order to compare women to men, we created three
different groups of male subjects, considering each women
group mean age plus one standard deviation and using
unweighted data. Male groups were as follows: 1) those
between 18 and 45 years old (mean age of pre-menopause
womenwas 35.62 years old, SD=9.22); 2) those between 46
and 57 years old (mean age of peri-menopause women was
50.42 years old, SD=6.60); and 3) those from 58 years and
older (mean age of post-menopause women was 63.67 years
old, SD=10.48).
Respondents were asked about suicide ideation during the
previous 12-months. The specific question was: “Have you
seriously thought about committing suicide during the last
12-months? (Yes/No)”.
The presence of a 12-month mood disorder (major
depression episode, dysthymic disorder) and anxiety disorder
(social phobia, specific phobia, generalised anxiety disorder,
agoraphobia and panic disorder) was evaluated with version
3.0 of the World Health Organization's (WHO) Composite
International Diagnostic Interview (CIDI 3.0), developed and
adapted by the WHO to be used in the WHO-World Mental
Health Survey Initiative (Kessler and Ustun, 2004). 12-month
mental disorders were combined in order to create four
categories: no mental disorders, only mood disorders, only
anxiety disorders, and comorbid mood and anxiety disorders.
2.3. Statistical analyses
We report prevalence of suicide ideation for women and
for each “comparison” age-group of men.
Logistic regression analyses were performed to estimate
the association of suicide ideation and reproductive cycle in
women (using the “comparison” group for men when
analysing data regarding men), adjusting by mental disorder
categories and socio-demographics (marital status, number
of children, and employment status). The logistic regression
model carried out with the women's sample was also
adjusted by age. Collinearity between age and reproductive
cycle was tested using the VIF index (VIF=3.46). As VIF value
was under 10, we assumed that these variables were not
collinear.
Data were weighted to adjust for differences in the
probability of selection of respondents within households,
differential non-response, to adjust for residual differences
between sample and country population, and to account for
the different questionnaire itineraries.Statistical analyses were carried out using the Stata Soft-
ware 9.2.
3. Results
Peri-menopausal women showed seven times higher pre-
valence of suicide ideation (7.8%) than the other groups (1.1%
for pre-menopause and 1.0% for post-menopause; p=0.004)
(Table 1). The prevalence of suicide ideation for men was very
similar among groups (between 0.6% in the older group and
1.0% for those aged between 46 and 57 years; p=0.77).
Table 2 shows the prevalence of suicide ideation across
reproductive cycle in women by mental disorder category.
Compared to pre and post-menopausal women without
mental disorders, women in their peri-menopause showed
higher prevalence of suicide ideation.
The association of suicide ideation with peri-menopause
was significant after adjusting by mental disorders and socio-
demographics (OR=9.01; 95%CI 1.88–43.26 compared to pre-
menopausal women; OR=6.67; 95%CI 1.34–33.25 compared
to post-menopausal women). On the other hand, the oldest
men showed a decreased odds for presenting suicide ideation
(OR=0.02 95% CI 0.01–0.73). The presence of only mood
disorders or comorbid mood and anxiety disorders was
associated to an increased probability of suicide ideation
both, in men and women (data not shown but available upon
request). By contrast, the presence of only anxiety disorders did
not show any significant association.
Interaction between reproductive cycle and mental dis-
orders in women was not statistically significant.
4. Discussion
The results of the present study should be interpreted in
the context of the following limitations. First, some categories
showed very few individuals. Second, menopausal status was
assessed by means of participants' self report, and no
hormone level analyses were considered. Third, the cross-
sectional design of our study does not allow us to conclude
causal relationship between variables. Fourth, we do not
know if there are country differences regarding reproductive
cycle and suicide ideation since appropriate comparisons
among countrieswere not possible due to limited sample size.
Despite the above limitations, results show that there is an
increased risk of suicide ideation among women in their peri-
menopause compared with women in their pre or post-
menopause. This finding was independent of mood and
anxiety disorders.
147J. Usall et al. / Journal of Affective Disorders 116 (2009) 144–147The association between peri-menopause and increased
suicide ideation could be partially explained by the relation
between oestrogens and serotonin. There is evidence sug-
gesting that oestrogens enhance serotonergic activity (Hal-
breich et al., 1999). Low serotonergic function appears to
increase suicide risk in those with predisposing factors (Baca-
Garcia et al., 2003; Mann, 1998). In the peri-menopause
period, especially at an early stage, there is an intense
fluctuation in serum levels of gonadal steroids. The “oestro-
genwithdrawal theory” proposes that the onset or worsening
of mood symptoms in peri-menopausal women result from
an abrupt hypoestrogenic state. This does not occur during
the menopause when hormone levels become more stable
(Genazzani et al., 2005). Such fluctuation could also explain
the increased suicide ideation regardless depressive symp-
toms. However, this should be considered as an speculation
since we could not derive this conclusion from our results.
Similar to previous work (Bernal et al., 2007), we found
that the presence of 12-monthmood and comorbidmood and
anxiety disorders was associated to suicide ideation.
Among sociodemographic variables, we found that the
oldest men (58 years and older) showed a reduced risk of
suicide ideation. It has been suggested that different age
cohorts show variable rates of suicidal thoughts and beha-
viours, and that rates of suicidal ideation decrease with age
(Fairweather et al., 2007).
To conclude, this is the first European epidemiological
study evaluating the relationship between women reproduc-
tive life cycle and suicidal ideation. Our results highlight the
importance of women reproductive cycle on it. Special
attention should be paid to women in their peri-menopause
since they are at an increased risk for suicide ideation.
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